The SemaPen approach: supporting safe, individualised care If you're feeling confused by the swirl of hype and misinformation, trust me I've been there
Currently, the main clinical drugs for MASLD are lipid-lowering drugs, insulin sensitizers, anti-fibrotic and thyroid hormone drugs
wound-study protocols may exclude sensitivity to copper, peptides, excipients, adhesives, or dressings
Its important to work with a doctor to manage symptoms and find a treatment plan
December 17, 2025: Federal Litigation Created for People Who Lost Their Vision After Taking Ozempic On December 15, 2025, the Joint Panel on Multidistrict Litigation (JPML) approved a request to consolidate lawsuits filed by people who experienced vision loss after taking Ozempic and other GLP-1 drugs
Psychological and pharmacological interventions are considered the first line of treatment for eating disorders